Glenmede Trust
ISEE

Glenmede Trust’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Glenmede Trust’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,315
Closed -$310K – 1354
2022
Q3 		$310K Buy
+17,315
New +$227K ﹤0.01% 943
2016
Q4 		– Sell
-5,172
Closed -$238K – 2652
2016
Q3 		$238K Buy
+5,172
New +$292K ﹤0.01% 1152

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Glenmede Trust's ISEE Position: Q4 2022 in Review

Glenmede Trust sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 17,315 shares — an estimated $310K sold.

Glenmede Trust first reported a position in ISEE in Q3 2016 and held it in 2 quarters. The position peaked at $310K in Q3 2022. 223 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

  • Glenmede Trust reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Glenmede Trust sold 17,315 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $310K.
  • Glenmede Trust first reported a position in IVERIC bio, Inc. Common Stock in Q3 2016 and held it in 2 quarters.
  • Glenmede Trust's IVERIC bio, Inc. Common Stock position peaked at $310K in Q3 2022.
  • 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Glenmede Trust's 13F filing for Q4 2022, filed 14 Feb 2023.